Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Feb 8, 2022
- Accession no.
- 0001773751-22-000023
- Filed
- Feb 8, 2022
- Trade date
- Dec 29, 2021-Jan 20, 2022
- Filing delay
- 41 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $7.75K. It was filed 41 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2022 | Class A Common Stock | PPurchaseAcquired | +1,500 | $5.17 | +$7,755 | 1,500 | Indirect | |
| Dec 29, 2021 | Class A Common Stock | GGiftDisposed | −4,000,000 | $0.00 | $0 | 1,357,635 | Indirect | |
| Dec 29, 2021 | Class A Common Stock | GGiftAcquired | +4,000,000 | $0.00 | $0 | 4,000,000 | Indirect | |
| Dec 29, 2021 | Class A Common Stock | GGiftDisposed | −1,000,000 | $0.00 | $0 | 357,635 | Indirect | |
| Dec 29, 2021 | Class A Common Stock | GGiftAcquired | +1,000,000 | $0.00 | $0 | 1,000,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.